Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
The larger figures were suspected covid cases and the smaller ones both suspected and confirmed. What this would mean is that if all the suspected cases were actual cases then taking the vaccine has only a small chance of stopping you get covid. As the author says way beneath the 50 per cent fda threshold. Of course its difficult to say how many covid suspected cases are actusl covid cases. However, if we said one half or just one third then the stats are still much much less compelling than the 95 per cent they have suggested.
Furthermore, it must be pointed out that the suspected cases would only generally have been suspected because of symptoms. We dont know how many in both the placebo and vaccinated groups has covid without grounds for suspecting.
Basically we can conclude that the vaccine does greatly reduce the number of people that get seriously ill but most likely is not stopping many if any people getting the virus or transmitting it.
This is all lies by omission. We were sold a story about immunity which is nonsense.
The question would be what' the quickest you could get start to finish throughput with a given person. That would be a lot more than a few minutes. Okehurst and Monkshood etc. Might know how long that takes. It seems they would get the samples from a bunch of people, label and prep them, put them through the machine at the same time and then get the results.
Its not avacta. Might be a company working with or about to work with avacta. BBI was mentioned but does youd call them a major global oem. Could be govmt and avacta have invplve someone like GSK.
The other issue is whether the supply starts early enough to relate to the avacta project though I do recall they were going to start even before the framework start date.
The situation does suggest an NDA and therefore we may have contracted with several other manufacturers as well. SE Asian manufacturers were being spoken with by Avacta and something on this front may have already been put in place. Would be nice to see 100s of millions produced by spring
Travel light. I think free trade has shown itself to be a fairy tale as regards critical kit in a pandemic. If I were govmt looking at probably the best test by far I would sew every bit of possible capacity up from home and abroad. If another country wants some I would make a deal: you want some you make them through tech transfer to companies in your country and allocate us a slice of what tou make. Its pulled the veil down that in a crisis its every country for themselves - no real solidarity.
I think the tweet also puts perspective on Abingdon going to market for funds to expand capa ity. Speculation that they will largely use added capacity to manufacture for Avacta now has more meat to it. We can also say that if Odx has jumped off the fence its sat on for some time it must have been for a pronounced reason - something gave them confidence that they needed to get their skates on. They normally take a month to start manufacturing tests that have been produced by others so their capacity will probably come on board in feb and will ramp to a share of 2m lfts per week that they aim to produce by April. I think Avacta have enough evidence now to get other manufacturers on board
I have been impressed with the Odx ramp plan. They were thinking of working with Avacta. Something positive must have been behind them getting off the fence and doing so. That is good derisking for shareholders - Odx effectively deciding that work with Avacta has the potential to make the ramp stronger and more sustainable
It should be clear Merchant from all the lfds currently out there that antibodies are simply not good enough. So about all you ha e left is optimers and affimers. Where is the research or factual evidence to support the former being better than the latter? Thats right none. Plenty to support the reverse conclusion. Actually read the avacta rnses properly and you will see it, plus all the research papers on affimers.
Its up 28 per cent in US
You just did mention it. You are allowed. There are lots of viruses that have gone into humans as a result of poor treatment of animals - factory farming and caging wild animals in cramped conditions at markets etc. This is a problem in the West as well as China. China is also one of the worst culprits for poor hygiene standards -which may have been a big factor here. Then there is secrecy and suppression which meant that the virus was able to get out of wuhan and abroad at scale very easily. Finally, we dont know the specific cause of this. From pangolins maybe. But equally there are biological institutes run by governments that experiment with and alter viruses as well as often also chemical and radiological agents . Porton Down has had one for over a 100 years. China has one on the outskirts of Wuhan. There are several books which document accidental and deliberate releases of agents and viruses etc. in both war and peace conditions on individuals and across whole geographic areas. This could be the cause of the pandemic but we dont know that its just a possibility.
Just to bring it back to the useful stuff. Ginola seem to be providing equipment for the secondary manufacture according to Bidstats. Specifically for semi automating the wrapping of the LFD to keep it dust and damp free etc. The reason the govmt are doing this is explained. To provide for surge in LFD demand in recognition that it is difficult to get such equipment quickly - 12 weeks lead time. I imagine the govmt will just want the machinery to be employed making the best domestic test or tests. I imagine they will encourage lfd manufacturers also to divert to best test or tests. I imagine lfd companies in uk probably already have considerable wrapping machines and they probably have considerable of everything else but this is govmt in times of national emergency doing all they can to help companies be ready to ramp quickly. The companies are being freed up - they simply make stuff to order with relief from much of the capital cost and attendant commercial risk of equipping manufacturing to a higher level. Its win win because the govmt gets better sovereign supply in return - including potentially supply of a sovereign best in class test. If there are more of these contracts in Jan I would take it as a sign of even higher govmt confidence in the forthcomingness of quality sovereign supply.
If you invested without knowing the catalysts that was poor decision making. If you are now looking back its because, not knowing the catalysts you cant actually work out if you have made a good decision. I am not sure you are cut out for shares if you jump around without doing your own research. Good luck because without research you will need more than your fair share.
I think yes CS affimers are the real deal. The company has great rech, great tests and great partnerships. It perhaps just needs to be savvy enough not to avoid mistakes (medusa, reliance of saliva lfd and reliance on slow govmt for validation), make its actions more dynamic and decisive (eg. seize the nettle of own validations sooner, bring on swab lfd) and get better at clarity in communications
What would be the point of a test developer simply developing a test on affimers that is already approaching valudation. And manufacturers would surely just want to tech transfer the avacta bbi test to save time and risk